Aporte a la rutina de la trinchera asistencial donde los conocimientos se funden con las demandas de los pacientes, sus necesidades y las esperanzas de permanecer en la gracia de la SALUD.
miércoles, 30 de marzo de 2011
National Guideline Clearinghouse | Treatment of anemia with erythropoietic agents in patients with cancer – adaption/adoption of ASH-ASCO guidelines.
Guideline Title
Treatment of anemia with erythropoietic agents in patients with cancer – adaption/adoption of ASH-ASCO guidelines.
Bibliographic Source(s)
Shehata N, Walker I, Quirt I, Imrie K, Haynes AE, Trudeau M, Hematology Disease Site Group. Treatment of anemia with erythropoietic agents in patients with cancer -- adaption/adoption of ASH-ASCO guidelines. Toronto (ON): Cancer Care Ontario (CCO); 2010 Jan 15. 37 p. (Evidence-based series; no. 6-11). [40 references]
Guideline Status
This is the current release of the guideline.
The EVIDENCE-BASED SERIES report, initially the full original Guideline, over time will expand to contain new information emerging from their reviewing and updating activities.
Please visit the Cancer Care Ontario Web site for details on any new evidence that has emerged and implications to the guidelines.
guidelines:
http://www.cancercare.on.ca/common/pages/UserFile.aspx?fileId=63144
FULL-TEXT:
National Guideline Clearinghouse | Treatment of anemia with erythropoietic agents in patients with cancer – adaption/adoption of ASH-ASCO guidelines.
No hay comentarios:
Publicar un comentario